Literature DB >> 29300807

Immune-related adverse events of immune checkpoint inhibitors and the impact of sex-what we know and what we need to learn.

B C Özdemir1, G Coukos1, A D Wagner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29300807     DOI： 10.1093/annonc/mdx818

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.

Authors:  Alessio Cortellini; Sebastiano Buti; Daniele Santini; Fabiana Perrone; Raffaele Giusti; Marcello Tiseo; Melissa Bersanelli; Maria Michiara; Antonino Grassadonia; Davide Brocco; Nicola Tinari; Michele De Tursi; Federica Zoratto; Enzo Veltri; Riccardo Marconcini; Francesco Malorgio; Carlo Garufi; Marco Russano; Cecilia Anesi; Tea Zeppola; Marco Filetti; Paolo Marchetti; Andrea Botticelli; Gian Carlo Antonini Cappellini; Federica De Galitiis; Maria Giuseppa Vitale; Roberto Sabbatini; Sergio Bracarda; Rossana Berardi; Silvia Rinaldi; Marianna Tudini; Rosa Rita Silva; Annagrazia Pireddu; Francesco Atzori; Rita Chiari; Biagio Ricciuti; Daniela Iacono; Maria Rita Migliorino; Antonio Rossi; Giampiero Porzio; Katia Cannita; Valeria Ciciarelli; Maria Concetta Fargnoli; Paolo Antonio Ascierto; Corrado Ficorella
Journal:  Oncologist       Date:  2019-02-22

Review 2.  Sex and Gender Differences in Anticancer Treatment Toxicity: A Call for Revisiting Drug Dosing in Oncology.

Authors:  Berna C Özdemir; Camille L Gerard; Cristina Espinosa da Silva
Journal:  Endocrinology       Date:  2022-06-01       Impact factor: 5.051

3.  Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database.

Authors:  Alessandro Ceschi; Roberta Noseda; Karine Palin; Katia Verhamme
Journal:  Front Pharmacol       Date:  2020-05-04       Impact factor: 5.810

Review 4.  The impact of sex and gender on immunotherapy outcomes.

Authors:  Sabra L Klein; Rosemary Morgan
Journal:  Biol Sex Differ       Date:  2020-05-04       Impact factor: 5.027

Review 5.  Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management.

Authors:  Zoe Apalla; Bernardo Rapoport; Vincent Sibaud
Journal:  Int J Womens Dermatol       Date:  2021-10-23

6.  Lower risk of severe checkpoint inhibitor toxicity in more advanced disease.

Authors:  Rik J Verheijden; Anne M May; Christian U Blank; Astrid A M van der Veldt; Marye J Boers-Sonderen; Maureen J B Aarts; Franchette W P J van den Berkmortel; Alfonsus J M van den Eertwegh; Jan Willem B de Groot; Jacobus J M van der Hoeven; Geke A P Hospers; Djura Piersma; Rozemarijn S van Rijn; Albert J Ten Tije; Gerard Vreugdenhil; Michiel C T van Zeijl; Michel W J M Wouters; John B A G Haanen; Ellen Kapiteijn; Karijn P M Suijkerbuijk
Journal:  ESMO Open       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.